Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

查看全文 作　　者：Manli [1]Wang;Ruiyuan [2]Cao;Leike [1]Zhang;Xinglou [1]Yang;Jia [1]Liu;Mingyue [1]Xu;Zhengli [1]Shi;Zhihong [1]Hu;Wu [2]Zhong;Gengfu [1]Xiao

机构地区：[1]State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,430071 Wuhan,China;[2]National Engineering Research Center for the Emergency Drug,Beijing Institute of Pharmacology and Toxicology,100850 Beijing,China

出　　处：《Cell Research》索引2020年第30卷第3期,共3页

摘　　要：Dear Editor,In December 2019,a novel pneumonia caused by a previously unknown pathogen emerged in Wuhan,a city of 11 million people in central China.The initial cases were linked to exposures in a seafood market in Wuhan.1 As of January 27,2020,the Chinese authorities reported 2835 confirmed cases in China's Mainland,including 81 deaths.Additionally,19 confirmed cases were identified in Hong Kong,Macao and Taiwan,and 39 imported cases were identified in Thailand,Japan,South Korea,United States,Vietnam,Singapore,Nepal,France,Australia and Canada.The pathogen was soon identified as a novel coronavirus(2019-nCoV),which is closely related to sever acute respiratory syndrome CoV(SARS-CoV).2 Currently,there is no specific treatment against the new virus.Therefore,identifying effective antiviral agents to combat the disease is urgently needed. 关键词：CANADA MAINLAND emerged

相关文献

参考文献（11）
引证文献（619）
耦合文献（0）

参考文献(11)

引证文献(619)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

参考文献(11)

引证文献(619)

用户提示